Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone vs Torasemide in Hypertension (ALTUM)
NCT06413082Phase 3Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Feb 2021
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of torasemide, spironolactone in hypertension (HTN), sponsored by IRCCS Ospedale San Raffaele. Started Feb 2021; status: completed.
02
Drugs
torasemidespironolactone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT06413082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06413082.